NSEDCP
NJ State Employees Deferred Compensation Plan’s Pacific Biosciences PACB Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $124K | Hold |
100,000
| – | – | 0.01% | 414 |
|
|
2025
Q1 | $118K | Hold |
100,000
| – | – | 0.02% | 418 |
|
|
2024
Q4 | $183K | Hold |
100,000
| – | – | 0.02% | 428 |
|
|
2024
Q3 | $170K | Hold |
100,000
| – | – | 0.02% | 442 |
|
|
2024
Q2 | $137K | Hold |
100,000
| – | – | 0.02% | 443 |
|
|
2024
Q1 | $375K | Hold |
100,000
| – | – | 0.05% | 337 |
|
|
2023
Q4 | $981K | Hold |
100,000
| – | – | 0.14% | 176 |
|
|
2023
Q3 | $835K | Hold |
100,000
| – | – | 0.13% | 178 |
|
|
2023
Q2 | $1.33M | Hold |
100,000
| – | – | 0.19% | 123 |
|
|
2023
Q1 | $1.16M | Hold |
100,000
| – | – | 0.18% | 133 |
|
|
2022
Q4 | $818K | Hold |
100,000
| – | – | 0.13% | 171 |
|
|
2022
Q3 | $581K | Hold |
100,000
| – | – | 0.1% | 216 |
|
|
2022
Q2 | $442K | Hold |
100,000
| – | – | 0.07% | 278 |
|
|
2022
Q1 | $910K | Hold |
100,000
| – | – | 0.12% | 175 |
|
|
2021
Q4 | $2.05M | Hold |
100,000
| – | – | 0.26% | 97 |
|
|
2021
Q3 | $2.56M | Hold |
100,000
| – | – | 0.35% | 77 |
|
|
2021
Q2 | $3.5M | Hold |
100,000
| – | – | 0.46% | 50 |
|
|
2021
Q1 | $3.33M | Hold |
100,000
| – | – | 0.47% | 48 |
|
|
2020
Q4 | $2.59M | Hold |
100,000
| – | – | 0.4% | 65 |
|
|
2020
Q3 | $987K | Hold |
100,000
| – | – | 0.18% | 117 |
|
|
2020
Q2 | $345K | Hold |
100,000
| – | – | 0.06% | 288 |
|
|
2020
Q1 | $306K | Hold |
100,000
| – | – | 0.07% | 280 |
|
|
2019
Q4 | $514K | Hold |
100,000
| – | – | 0.09% | 263 |
|
|
2019
Q3 | $516K | Hold |
100,000
| – | – | 0.09% | 237 |
|
|
2019
Q2 | $605K | Buy |
100,000
+20,000
| +25% | +$121K | 0.11% | 191 |
|
|
2019
Q1 | $578K | Buy |
80,000
+30,000
| +60% | +$217K | 0.11% | 208 |
|
|
2018
Q4 | $370K | Buy |
+50,000
| New | +$370K | 0.08% | 314 |
|